Literature DB >> 9676535

Advances in multimodality therapy for laryngeal cancer.

J F Carew1, J P Shah.   

Abstract

Combined induction chemotherapy and external beam radiation therapy is an effective treatment for selected patients with advanced-stage laryngeal cancer. The larynx can be preserved in two-thirds of patients receiving this treatment. Investigations continue to evaluate the ideal treatment regimen, the delivery of chemotherapy, patient selection, biologic markers predicting response, functional outcome, and the effectiveness of this treatment at other sites.

Entities:  

Mesh:

Year:  1998        PMID: 9676535     DOI: 10.3322/canjclin.48.4.211

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  4 in total

Review 1.  Advanced larynx cancer.

Authors:  Scott E Strome; Eric C Weinman
Journal:  Curr Treat Options Oncol       Date:  2002-02

2.  Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer Hep-2 cells.

Authors:  Wanzhong Yin; Ping Wang; Xin Wang; Wenzhi Song; Xiangyan Cui; Hong Yu; Wei Zhu
Journal:  Braz J Med Biol Res       Date:  2013-06-12       Impact factor: 2.590

3.  Induction chemotherapy in patients with resectable laryngeal cancer: A meta-analysis.

Authors:  Pei Gao; Liang Gong; Xuefeng Wang
Journal:  Mol Clin Oncol       Date:  2018-06-05

4.  Knockdown of Circular RNA hsa_circ_PVT1 Inhibited Laryngeal Cancer Progression via Preventing wnt4/β-Catenin Signaling Pathway Activation.

Authors:  Feng Yu; Ying Lin; Mao-Mao Ai; Guo-Jie Tan; Jia-Li Huang; Zi-Rou Zou
Journal:  Front Cell Dev Biol       Date:  2021-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.